ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA
24 oct. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA
ONWARD® Medical lance une augmentation de capital d’un montant d’environ 40 millions d’euros dont 22,5 millions d’engagement ferme de la part d’Ottobock SE & Co. KGaA
22 oct. 2024 14h21 HE
|
ONWARD Medical NV
NE PAS DISTRIBUER OU DIFFUSER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, AU CANADA, EN AUSTRALIE OU AU JAPON OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE LA DISTRIBUTION OU LA DIFFUSION SERAIT...
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA
22 oct. 2024 11h45 HE
|
ONWARD Medical NV
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40M including EUR 22.5M Cornerstone Investment from Ottobock SE & Co. KGaA
ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman
21 oct. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Changes to Board of
Directors, Including Addition of Medtech Leader Rob ten
Hoedt as Incoming Chairman
ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec
15 oct. 2024 01h30 HE
|
ONWARD Medical NV
CE COMMUNIQUÉ DE PRESSE CONTIENT DES INFORMATIONS PRIVÉES AU SENS DE L'ARTICLE (7)(1) DU RÈGLEMENT EUROPÉEN SUR LES ABUS DE MARCHÉ (596/2014) L'entreprise obtient les droits exclusifs pour intégrer...
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology
15 oct. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology
ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
20 sept. 2024 13h45 HE
|
ONWARD Medical NV
La société a des racines françaises et des liens significatifs avec la France La société collabore étroitement avec le CEA-Clinatec, institut de recherche biomédicale de renommée mondiale financé par...
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
19 sept. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière
19 sept. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine pour restaurer le mouvement après une lésion de la moelle épinière
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
10 sept. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update